Quick Jump Daily Digest
Thank you for your interest in the Quick Jump Daily Digest. Get notified of all new content on QJ in our free Daily Digest. To subscribe, enter your email address below and click the subscribe button.
MU developing nano-engineered devices to cure cancer and HIV |
Listed in: Tags: Columbia, gaming accessories, HIV, Missouri, nanotechnology, Nems
Ó
Medical science is always on the breakthrough to find cures for so many life-threatening illnesses these days. A recent project headed by University of Missouri-Columbia engineers based on nanotechnology aims to develop a small but powerful device capable of effectively delivering drugs to help treat these conditions.So far, the project is in its testing phase and will be focusing on fighting various diseases on a microscopic level, such as destroying tumors, kidney stones, ulcers as well as hopefully treating cancer and HIV. Through a fusion of microchip-based technology and nanotechnology, the device triggers a reaction resulting in super sonic shock waves which will make infected cells permeable for drug interaction.
The project is headed by Shubhra Gangopadhyay, an electrical and computer engineering professor in the College of Engineering and the head of the University's International Center for Nano/Micro Systems and Nanotechnology.
Other practical uses of the technology include the dispersal of drug-carrying nanoparticles called the nanosponge into the body. This nanosponge will then target specific cells and areas that have been infected with disease. Also, through the delivery of gold nanoparticles, doctors can also track drug movement and the spread of disease throughout the body.
Such nanoparticles contain no harmful components and will be harmless to the body. The device will, however, need as many as three more years of additional testing before it can be made available to pharmaceutical companies. Nems/Mems Works, LLC will market the device and the various nanoparticles associated with the study.
| This story sucks? This story rocks! |
|
|
